In yesterday’s Wall Street session, McKesson Corporation (NYSE:MCK) shares traded at $374.05, up 0.01% from the previous session.
17 analysts cover McKesson Corporation (NYSE:MCK), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $460.00 and a low of $376.00, we find $431.00. Given the previous closing price of $374.01, this indicates a potential upside of 15.24 percent. MCK stock price is now -1.22% away from the 50-day moving average and 8.35% away from the 200-day moving average. The market capitalization of the company currently stands at $53.12B.
The stock has received a hold rating from 3 analysts and a buy rating from 11. Brokers who have rated the stock have averaged $427.32 as their price target over the next twelve months.
, while ‘Deutsche Bank’ rates the stock as ‘Buy’.
In other news, Schechter Lori A., EVP, Chief Legal Officer & GC sold 2,500 shares of the company’s stock on Dec 09. The stock was sold for $949,475 at an average price of $379.79. Upon completion of the transaction, the EVP, Chief Legal Officer & GC now directly owns 4,178 shares in the company, valued at $1.56 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 10, EVP, Chief Legal Officer & GC Schechter Lori A. sold 2,500 shares of the business’s stock. A total of $977,550 was realized by selling the stock at an average price of $391.02. This leaves the insider owning 6,678 shares of the company worth $2.5 million. Insiders disposed of 286,536 shares of company stock worth roughly $107.18 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in MCK stock. A new stake in McKesson Corporation shares was purchased by WCM INVESTMENT MANAGEMENT, LLC during the first quarter worth $330,990,000. GREAT WEST LIFE ASSURANCE CO /CAN/ invested $80,356,000 in shares of MCK during the first quarter. In the first quarter, AUSTRALIANSUPER PTY LTD acquired a new stake in McKesson Corporation valued at approximately $35,490,000. JUNTO CAPITAL MANAGEMENT LP acquired a new stake in MCK for approximately $27,024,000. WALLEYE TRADING LLC purchased a new stake in MCK valued at around $21,629,000 in the second quarter. In total, there are 1,587 active investors with 89.30% ownership of the company’s stock.
On Thursday morning McKesson Corporation (NYSE: MCK) stock kicked off with the opening price of $374.00. During the past 12 months, McKesson Corporation has had a low of $237.61 and a high of $401.78. The fifty day moving average price for MCK is $378.58 and a two-hundred day moving average price translates $345.58 for the stock.
The latest earnings results from McKesson Corporation (NYSE: MCK) was released for Jun, 2022. According to the Medical Distribution Company, earnings per share came in at $5.83, beating analysts’ expectations of $5.28 by 0.55. This compares to $0.00 EPS in the same period last year. The net profit margin was 0.80% and return on equity was -112.30% for MCK. The company reported revenue of $70.16 billion for the quarter, compared to $66.58 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.38 percent. For the current quarter, analysts expect MCK to generate $70.2B in revenue.
Moreover, the firm recently paid out its quarterly dividend on 01/03/2023. Investors who held shares on 12/01/2022 were paid a $0.54 dividend. On an annualized basis, this represents a $2.16 dividend and a 0.58% percent yield. There was an ex-dividend date of 11/30/2022 for this dividend. In terms of dividend payout ratio, MCK is presently at 13.20%.
McKesson Corporation(MCK) Company Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.